China Universal Asset Management Co., Ltd. Sutro Biopharma, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 16,540 shares of STRO stock, worth $14,059. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,540
Previous 17,484
5.4%
Holding current value
$14,059
Previous $32,000
68.75%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding STRO
# of Institutions
119Shares Held
60.6MCall Options Held
95.8KPut Options Held
38.5K-
Suvretta Capital Management, LLC New York, NY7.46MShares$6.34 Million0.21% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$5.87 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.44MShares$4.63 Million0.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.43MShares$3.77 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.4MShares$3.74 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $44.3M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...